Clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD)

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/483572/2012
Effective from01/09/2012
KeywordsChronic obstructive pulmonary disease (COPD), airflow obstruction, relief of symptoms, maintenance treatment
DescriptionThis document provides guidance for the clinical evaluation of new medicinal products for the treatment of chronic obstructive pulmonary disease (COPD). It specifically focuses on the maintenance treatment of COPD.

Document history

First version

Current version

PDF iconAdopted guideline


Overview of comments


PDF iconDraft guideline


PDF iconConcept paper

In operation: 01/09/2012–present


Published: 22/11/2012


Published: 20/09/2010


Published: 19/0/2009

Superseded document PDF iconPoints to consider Pubished: 19/05/1999

Related content

How useful was this page?

Add your rating